UNIVERCELLS
Key Highlights
- UNIVERCELLS is a pioneer in the biotech industry, focusing on transformative vaccine and therapeutic design.
- The company's innovative approach is based on the belief that small adaptations can lead to significant advancements.
- UNIVERCELLS employs a team of highly skilled scientists and entrepreneurs dedicated to creating impactful biotech solutions.
- The company's work is driven by a commitment to scientific excellence and a vision of improving global health outcomes.
- UNIVERCELLS is a leader in leveraging technology and bioprocess know-how to develop effective and accessible pharmaceutical solutions.
About UNIVERCELLS
UNIVERCELLS is a privately held biotech company based in Bruxelles, Belgium, founded in 2013. It specializes in innovative vaccine and therapeutic design and production, leveraging technology, bioprocess know-how, and entrepreneurial spirit. The company focuses on transformative thinking and small adaptations to drive significant change in the pharmaceutical and biotech industry.
UNIVERCELLS employs a team of 43 scientists and entrepreneurs who are dedicated to creating transformative platforms. Their mission is to enhance the way vaccines and therapeutics are designed and produced, ensuring they are effective and accessible for humanity's benefit. The company's approach is rooted in the belief that small, evolutionary changes can lead to major advancements.
By focusing on innovation and operational excellence, UNIVERCELLS aims to lead the biotech industry in developing cutting-edge solutions. Their work is driven by a commitment to scientific excellence and a vision of a healthier future for all.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Private Company |
Subsidiaries & Divisions
Why Contact UNIVERCELLS?
B2B professionals should contact UNIVERCELLS for partnerships in innovative biotech solutions, vendor opportunities in vaccine and therapeutic production, and potential collaborations with leading scientists and entrepreneurs in the field.
Who Should Contact UNIVERCELLS for Business?
Sales teams selling biotech solutions, recruiters seeking roles in pharmaceutical and biotech innovation, and partners offering technology and bioprocess expertise should reach out to UNIVERCELLS.
Categories
- biotech innovation
- vaccine design
- therapeutic production
- bioprocess know-how
- pharmaceutical solutions
- entrepreneurial spirit
- transformative platforms
- scientific excellence
- global health
- biotech solutions
More Biotechnology Companies
Frequently Asked Questions
- Who is the CEO of UNIVERCELLS?
- Mathias Garny is the CEO of Univercells Technologies, a Univercells company.
- What is Mathias Garny's email at UNIVERCELLS?
- Mathias Garny's email address is m.garny@univercells.com.
- What does UNIVERCELLS do?
- Univercells provides innovative biomanufacturing technologies and next-generation bioprocessing solutions designed to make biologics and gene therapies more affordable through process intensification.
- How many employees does UNIVERCELLS have?
- UNIVERCELLS has approximately 42 employees.
- Where is UNIVERCELLS headquartered?
- Univercells is headquartered in Gosselies, Hainaut, Belgium.
- What industry is UNIVERCELLS in?
- UNIVERCELLS operates in Biotechnology, Pharmaceutical, Vaccine Development.
- When was UNIVERCELLS founded?
- UNIVERCELLS was founded in 2013.
- What is the email format at UNIVERCELLS?
- UNIVERCELLS uses the email format f.last@univercells.com.
- Is UNIVERCELLS still active?
- Yes, UNIVERCELLS was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to UNIVERCELLS?
- Research UNIVERCELLS's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to UNIVERCELLS?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with UNIVERCELLS